News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Potential New Drug Being Studied to Treat Off Times for Parkinsonís Patients

Cynapsus Therapeutics Inc., a specialty pharmaceutical company based in Toronto, is developing APL-130277, a fast-acting oral reformulation of apomorphine, a sublingual strip that dissolves under the tongue. The major advantage is that if approved, it would be easier for many to self-administer. Today, the only approved rapid rescue medication that can be used to treat symptoms during off periods need to be given by injection. Read more…